NanoString Technologies, Inc. updated earnings guidance for the year 2023. For the year, the company expects total revenue of $175 million to $180 million, as compared to the previous range of $175 million to $185 million.
NanoString Technologies, Inc.
Equities
NSTGQ
US63009R1095
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.128 USD | +5.26% | +2.40% | -82.90% |
May. 07 | Bruker's NanoString Secures Patent Case Win in Germany | MT |
May. 07 | First Amended Reorganization Plan and Disclosure Statement Filed by NanoString Technologies, Inc. | CI |
1st Jan change | Capi. | |
---|---|---|
-82.90% | 5.85M | |
-5.16% | 179B | |
+3.91% | 113B | |
-3.48% | 67.88B | |
+5.57% | 52.03B | |
+5.73% | 43.3B | |
+4.03% | 41.79B | |
+24.44% | 32.49B | |
+14.00% | 25.65B | |
-4.48% | 24.55B |
- Stock Market
- Equities
- NSTGQ Stock
- News NanoString Technologies, Inc.
- NanoString Technologies, Inc. Updates Earnings Guidance for the Year 2023